These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38532572)

  • 1. Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review.
    Kuzumi A; Yamashita T; Fukasawa T; Yoshizaki-Ogawa A; Sato S; Yoshizaki A
    Exp Dermatol; 2024 Mar; 33(3):e15064. PubMed ID: 38532572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and Their Receptors in Skin Diseases.
    Yoo EH; Lee JH
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
    Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
    Ruszczak Z
    Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.
    Ramer R; Hinz B
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of cannabinoids in dermatology.
    Sheriff T; Lin MJ; Dubin D; Khorasani H
    J Dermatolog Treat; 2020 Dec; 31(8):839-845. PubMed ID: 31599175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids as novel anti-inflammatory drugs.
    Nagarkatti P; Pandey R; Rieder SA; Hegde VL; Nagarkatti M
    Future Med Chem; 2009 Oct; 1(7):1333-49. PubMed ID: 20191092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids in dermatology: a scoping review.
    Eagleston LRM; Kalani NK; Patel RR; Flaten HK; Dunnick CA; Dellavalle RP
    Dermatol Online J; 2018 Jun; 24(6):. PubMed ID: 30142706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Endogenous Cannabinoids on the Mammalian Respiratory System: A Scoping Review of Cyclooxygenase-Dependent Pathways.
    Kolousek A; Pak-Harvey E; Liu-Lam O; White M; Smith P; Henning F; Koval M; Levy JM
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):434-444. PubMed ID: 37074668
    [No Abstract]   [Full Text] [Related]  

  • 10. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
    Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E
    Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases.
    Milando R; Friedman A
    Am J Clin Dermatol; 2019 Apr; 20(2):167-180. PubMed ID: 30542832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and autoimmune diseases: A systematic review.
    Katchan V; David P; Shoenfeld Y
    Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
    Tóth KF; Ádám D; Bíró T; Oláh A
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30845666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
    Bíró T; Tóth BI; Haskó G; Paus R; Pacher P
    Trends Pharmacol Sci; 2009 Aug; 30(8):411-20. PubMed ID: 19608284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
    Kicman A; Pędzińska-Betiuk A; Kozłowska H
    Eur J Pharmacol; 2021 Nov; 911():174560. PubMed ID: 34648805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020.
    Angelina A; Pérez-Diego M; López-Abente J; Palomares O
    Int Arch Allergy Immunol; 2020; 181(8):565-584. PubMed ID: 32526734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases.
    Zeng Y; Yang S; Liu Y; Tang Z; Zong X; Li X; Wang D
    Mini Rev Med Chem; 2023; 23(6):652-661. PubMed ID: 36424786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application.
    Kaminski NE; Kaplan BLF
    Adv Pharmacol; 2021; 91():1-59. PubMed ID: 34099105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.